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Summary 31 
The parasite Leishmania donovani causes a fatal disease termed visceral leishmaniasis. 32 
The process through which the parasite adapts to environmental change remains largely 33 
unknown. Here we show that aneuploidy is integral for parasite adaptation and that 34 
karyotypic fluctuations allow for selection of beneficial haplotypes, which impact 35 
transcriptomic output and correlate with phenotypic variations in proliferation and infectivity. 36 
To avoid loss of diversity following karyotype and haplotype selection, L. donovani utilizes 37 
two mechanisms: polyclonal selection of beneficial haplotypes to create coexisting 38 
subpopulations that preserve the original diversity, and generation of new diversity as 39 
aneuploidy-prone chromosomes tolerate higher mutation rates. Our results reveal high 40 
aneuploidy turnover and haplotype selection as a unique evolutionary adaptation mechanism 41 
that L. donovani uses to preserve genetic diversity under strong selection. This unexplored 42 
process may function in other human diseases, including fungal infection and cancer, and 43 
stimulate innovative treatment options.  44 
45 
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Introduction 50 
Rapid pathogen adaptation to novel environments is a major threat to human health.  In 51 
parasites evolving under constant host selection, fitness gains often cause increased 52 
pathogenicity1. Aneuploidy recently emerged as a key driver for evolutionary adaptation of 53 
fungal and protist pathogens2–4, in which chromosome copy number variations induce 54 
phenotypic changes through modulation of transcript and protein abundance5. In addition to 55 
its effect on gene count, aneuploidy impacts cellular phenotypes through the selection of 56 
beneficial alleles. While this phenomenon has received considerable attention in human 57 
genetics6 and cancer genome analysis7,8,9, the role of aneuploidy on allelic selection in 58 
genome evolution and adaptation in pathogenic eukaryotes remains poorly understood in 59 
most organisms, in spite of recent attention10,11. 60 
We addressed this question in the protozoan parasite Leishmania donovani, an 61 
important human pathogen that causes fatal visceral leishmaniasis12. During its life cycle 62 
Leishmania undergoes a major developmental transition from insect-stage promastigotes to 63 
mammalian-stage amastigotes, which adapts these parasites for extra- and intracellular 64 
survival, respectively13. In addition to environmentally-induced stage differentiation, 65 
Leishmania can adapt to a variety of unpredictable fluctuations inside its human host, 66 
notably pharmacological interventions. Such environment-genotype interactions likely select 67 
parasites for higher fitness and have important consequences on disease outcome as 68 
demonstrated by the emergence of drug resistant clinical isolates14,15. However, the 69 
underlying genetic mechanisms that drive short-term Leishmania evolution are still largely 70 
unknown. In the absence of classical transcriptional gene regulation, these early-branching 71 
eukaryotes often control protein abundance via gene and chromosome amplification10,16. 72 
This process is fueled by frequent asymmetric chromosome allotments, which cause 73 
4 
constitutive mosaicism17,18. This model has recently received new support19 with a large-74 
scale deep sequencing study of L. donovani field isolates showing a correlation between 75 
polysomy variations and changes in heterozygosity. Leishmania therefore represents an 76 
ideal non-conventional system to investigate how karyotype variations and allelic selection 77 
drive parasite fitness gains and how transient and stable aneuploidies impact the long-term 78 
evolutionary trajectory. 79 
 80 
Results 81 
Karyotype and haplotype selection in field isolates 82 
We first explored the impact of aneuploidy on allelic selection in Leishmania using the 83 
recently published sequencing data of 204 L. donovani field isolates19. These populations 84 
originate from independent evolutionary radiations that occurred after a population 85 
bottleneck caused by DDT vector control campaigns in the 1960s. This makes them a 86 
convenient benchmark to study genetic diversity dynamics. We conducted read-depth 87 
analyses on publicly available sequencing data sets19 to explore ploidy variations across 88 
culture-adapted isolates (Fig. 1a). Even though a large number of intermediate read-depth 89 
values suggest frequent mosaicism (Fig. 1a, Supplementary Table 1), the relatively high 90 
frequency of discrete polysomy levels other than disomic levels (notably trisomy) indicates 91 
that a large fraction of isolates may be homogenous for single or co-occurring aneuploidies 92 
(e.g chr 5, 9, 23 and 26, Fig. 1b). While all chromosomes are predominantly disomic except 93 
for chr 31, the overall karyotypic diversity is very high with the most frequent karyotype 94 
representing only about 10% of the 204 isolates.  95 
The frequent occurrence of karyotypic similarities among isolates suggests that the 96 
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corresponding aneuploidies may either have a common, monoclonal origin (i.e. one unique 97 
founding duplication) or result from frequent convergent processes (i.e. selection of several 98 
independent duplications of the same homologous chromosome). Relatively weak 99 
correlations between aneuploidy and SNP variation19 does not discriminate between these 100 
two possibilities. While clonal expansion of a single founder may underlie the most common 101 
aneuploidies (like chr 31, 5 or 26), their occurrence in karyotypically very diverse isolates is 102 
also compatible with a polyclonal origin. 103 
Under a polyclonal scenario, each culture-adapted isolate arises from the expansion 104 
of mixed subpopulations sharing some independently generated polysomies. This model is 105 
in good agreement with mosaicism, previously observed in cultured Leishmania major18. We 106 
analyzed allelic frequency distributions to evaluate the likelihood of polyclonal origin 107 
(Supplementary Fig. 1). In this analysis, well-defined peaks in the merged profiles of most 108 
chromosome allelic frequency distributions indicate that most heterozygote alleles are 109 
balanced similarly across isolates. For disomic profiles, we typically observed unimodal 110 
allelic frequency distributions centered at 50% (Supplementary Fig. 1a - left column). These 111 
observations are consistent with diploid asexual populations in which most alleles diffuse by 112 
random drift. 113 
Chromosomes with a read-depth level compatible with trisomy present us with a 114 
more complex situation. In these chromosomes, the merged allelic frequency profiles 115 
(Supplementary Fig. 1a – right column) revealed a continuum between the two extreme 116 
cases of pure unimodal (e.g. chr 1, Fig. 1c, Supplementary Fig. 1d bottom scenario) and 117 
pure bimodal (e.g. chr 5, Fig. 1c, Supplementary Fig. 1d other scenarios) allelic frequency 118 
distributions. In the absence of mosaicism, trisomies usually cause bimodal allelic frequency 119 
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distributions. Unimodal distributions like chr 1 therefore reflect population mosaicism as a 120 
consequence of a duplication scenario with both homologous chromosomes equally likely to 121 
be duplicated across the entire population of cells constituting an isolate, thus maintaining 122 
the original allelic frequency equilibrium of the disomic state (Supplementary Fig 1d). The 123 
coexistence of haplotypically different trisomies within the same isolate clearly indicates 124 
mosaicism, which strongly suggests a polyclonal origin. In contrast, bimodal allelic frequency 125 
distributions centered on 33 and 66%, like that observed for chr 5, reflect the collective 126 
doubling in relative frequency of half of the alleles and are characteristic of homogenous 127 
duplication of the same homologous chromosome within each isolate population (thus 128 
defining an identical haplotype). While the integration of various mosaicism combinations by 129 
sequencing analysis could cause similar read-depths, it is unlikely that mosaicism would also 130 
cause bimodal allelic frequency distributions centered on 33 and 66%. 131 
  Even though they occur in a large fraction of the isolates, chr 5 trisomies are most 132 
likely the result of a convergent process as suggested by their polyphyletic dispersion on the 133 
phylogenetic tree of the 204 filed isolates19. Given such a convergent process, we asked if 134 
these trisomies were selected as karyotypes or as specific haplotype combinations. 135 
Haplotype selection should cause increased homogeneity across isolates. We therefore 136 
measured allelic dispersion across trisomic isolates. We estimated the relative loss of 137 
heterozygosity (LOH) between disomic and trisomic isolates for each chromosome. This 138 
analysis shows that chr 5 had one of the lowest allelic diversity (highest average LOH) and 139 
suggests frequent selection of the same homologous chromosome among the trisomic 140 
isolates.  141 
On these same subsets of trisomic and disomic chromosomes, we measured the 142 
segregation variation (SV). SV is defined as the average ratio between the frequency of the 143 
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dominant allele in each trisomic isolate and its corresponding average frequency in disomic 144 
isolates. This index reflects the changes in segregation patterns between disomic and 145 
trisomic states and is highest for chromosomes that show a unimodal distribution at a 146 
disomic state and a bi-modal distribution at a trisomic state. As expected, we found chr 5 to 147 
have one of the highest SV ratio. We also found a strong correlation between LOH and SV 148 
across all chromosomes with the scatter plot displaying a clear continuum between chr 1 149 
and chr 29 (Fig. 1d). This observation is in agreement with our hypothesis that high levels of 150 
haplotype selection cause increased allelic homogeneity across isolates. These results 151 
confirm that bimodal allelic frequency profiles are more likely induced by a selection process 152 
rather than a monoclonal founding event. Monoclonal origin without haplotype selection 153 
would cause a high SV and low LOH. Interestingly, distinctly bimodal chr 5 trisomies coexist 154 
with unimodal trisomies of other chromosomes in a subset of the isolates (e.g. chr 12, 155 
Supplementary Fig. 2). This finding indicates that various levels of haplotypic selection can 156 
affect different chromosomes within the same parasite isolate. Altogether, the complex 157 
karyotypic and haplotypic variations across field isolates clearly favors a polyclonal mosaic 158 
origin as the most common scenario with diversity drawn from an equally diverse original 159 
population, as postulated by Sterkers et al.18. 160 
 161 
In vivo karyotype fluctuations 162 
Polyclonal origin implies a pre-existing population-wide karyotypic mosaicism within each 163 
individual isolate. Maintaining this degree of variability would require frequent polysomic 164 
fluctuations. We measured this effect by monitoring chromosomal copy number when re-165 
passaging an aneuploid field isolate (strain LdBPK282) through hamsters. The rapid shift to 166 
a predominant disomic karyotype in the field isolate analysed here (and an independent 167 
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isolate shown by Dumetz et al.20) demonstrates highly dynamic aneuploidy fluctuations (Fig. 168 
2a). It is unclear, however, if the observed aneuploidies during culture adaptation arise from 169 
expansion of existing subpopulations or constitute a reversible de novo phenomenon. We 170 
therefore examined this question applying single cell DNA-FISH analysis on liver and spleen 171 
amastigotes. We analyzed the experimental Sudanese L. donovani strain LD1S with 172 
available DNA-FISH probes to monitor aneuploidies for chr 5, 17, 22 and 27. Hamsters were 173 
infected with amastigotes isolated from infected hamster spleens that showed a disomic read 174 
depth for all chromosomes except tetrasomic chr 31 (see Supplementary Fig. 3a). For all 175 
chromosomes investigated, our analysis confirmed frequent in situ mosaic aneuploidies in 176 
liver and spleen (Fig. 2b). This pre-existing diversity can facilitate population-wide 177 
aneuploidies in response to environmental changes. This possibility is in line with the mosaic 178 
origin of aneuploidies observed in culture18. 179 
In vitro karyotype and haplotype selection 180 
While field isolate and in vivo analyses suggest that parasite adaptation relies on a 181 
mechanism dedicated to accommodate frequent aneuploidies, these observations only 182 
provide static snapshots of apparently highly dynamic fluctuations. To further elucidate this 183 
process, we used again the experimental strain LD1S. In contrast to L. donovani clinical 184 
isolates from the Indian sub-continent, this strain contains a larger number of heterozygous 185 
sites (23014 compared to a median of 1143 per field isolate), which makes it an ideal model 186 
for longitudinal monitoring of chromosome copy number variation and haplotype selection. 187 
We used HTSeq to follow hamster-derived LD1S amastigotes during adaptation to in vitro 188 
culture. Read depth analyses indicated that parasites rapidly establish stable trisomies for 189 
chr 5, 9, 23, and 26 between in vitro passages p2 (ca. 20 generations) and p10 (ca. 60 190 
generations) (Fig. 3a and Supplementary Fig. 3a). These karyotypic trajectories matched the 191 
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most common variations observed in the field isolates (Fig. 1a and b, Supplementary Fig. 1) 192 
and they were highly reproducible across two independent experiments20. Not all 193 
aneuploidies are stable and homogenous, however. For example, chr 20 underwent a 194 
transient trisomy between passages p2 and p20 (ca. 190 generations), while probable 195 
mosaic aneuploidies (Fig. 3a) occurred for chr 14 and 15 and were stably maintained as 196 
judged by their intermediate read-depth levels at p10 and p20. 197 
Population mosaicism in Leishmania major was previously examined on cultured 198 
promastigotes using a combination of sub-cloning and DNA-FISH analysis18. We used 199 
systematic comparison between p20 and eight individual sub-clones to model the original 200 
population complexity (Fig. 3b and Supplementary Fig. 3b). Haplotype and karyotype 201 
comparisons suggest that the eight clones may have arisen from at least two independent 202 
founding individuals (Supplementary Fig. 3c). Indeed, aneuploidies provide a powerful 203 
insight into haplotype phasing, due to systematic frequency shifts associated with duplicated 204 
homolog chromosome21. In this case, direct haplotype comparisons (Fig. 4a, Supplementary 205 
Fig. 4) clearly show how the allelic nature of chr 5 and chr 9 trisomies sets clones 1 and 8 206 
apart from the rest. For instance, the existence of two groups with differences of major 207 
alleles on chr 5 (1 and 8 vs the rest) indicates that these trisomies were established through 208 
duplications of different chr 5 homologs (i.e. same chr 5 homologue duplicated in clones 1 209 
and 8 that is different from the other clones). The most parsimonious reconstruction simply 210 
requires two trisomies of independent origin and is consistent with a high aneuploidy 211 
turnover18. This explanation also applies to chromosome 9 and further supports the common 212 
origin of clones 1 and 8. Sequencing 8 subclones has limited statistical power, and our 213 
speculation of two original founders does rely on a parsimonious hypothesis. Yet, the 214 
existence of clearly distinct subpopulations featuring similar aneuploidies further supports the 215 
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mosaic origin scenario, under which individual strains represent complex mixtures of stable, 216 
karyotypically distinct subpopulations. 217 
Between subpopulations, similar karyotypes and haplotypes likely reflect a form of 218 
convergence. At the karyotypic level, the most obvious indications of convergence occur on 219 
chr 5, 9 and 26, whose trisomies are shared across all clones despite their independent 220 
origins. Selection could also occur at the haplotypic level, with the clearest indication 221 
provided by chr 26 whose haplotype map shows a consistent selection of the same allelic 222 
combination across clones of different origin (Fig 4a). Unfortunately, the simultaneous 223 
haplotype/karyotype selection taking place on this chromosome makes it impossible to 224 
discriminate between purifying (lethality of one of the two possible trisomies) or positive 225 
(higher fitness of one trisomy) selection pressure being imposed on its haplotype. 226 
Chromosome 20 instead provides clear evidence for positive haplotype selection. This 227 
chromosome is disomic and heterozygous at p2, becomes trisomic at p10, but reverts back 228 
to disomy at p20 (Figs. 3a and 4b, Supplementary Fig. 5). After reversion, the allelic 229 
frequency profiles unexpectedly show a near-perfect homozygote disomy in 6 out of 8 clones 230 
(i.e. relatively flat allele frequency profile combined with a 60% decrease in the number of 231 
heterozygous sites, Fig. 4a and Supplementary Fig. 6). In chr 20, transient trisomy therefore 232 
provides an intermediate step to establish a homozygous disomy, whose selection 233 
contributes to positive fitness as previously seen on yeast22. 234 
 235 
Correlation of aneuploidies with phenotypic variations 236 
Since Leishmania primarily lacks classical gene regulation mechanisms, it has long been 237 
speculated that polysomy should result in proportional transcriptional fluctuations15 and that 238 
aneuploidy mediated gene expression changes could be a trait under selection. We used 239 
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HTSeq analysis to correlate read-depth levels between genome and transcriptome (Fig. 5a, 240 
Supplementary Fig. 7) and found a very high correlation for most chromosomes (r=0.72), 241 
with the notable exception of chr 31. In this chromosome that is predominantly tetrasomic 242 
across various Leishmania strains, transcriptomic output appears halved, suggesting some 243 
form of dosage compensation, which cancels the polysomic effect. We also found karyotypic 244 
fluctuations resulting from culture adaptation to correlate with rapidly increasing in vitro 245 
fitness as judged by the decreasing generation time (Fig. 5b, left panel). Concurrently with 246 
these variations the parasites showed decreased in vivo fitness as indicated by lower 247 
infectivity (Fig. 5b middle and right panels). To assess if these variations take place during 248 
the parasite life cycle, we separately sequence amastigotes obtained from spleen and liver 249 
from one infected hamster. We found significantly distinct allelic profile variations for chr 20, 250 
which showed a unimodal profile in liver and a bimodal profile in spleen (Fig. 5c, 251 
Supplementary Fig. 8), while read depth analysis indicated a disomic state in both tissues 252 
(Supplementary Fig. 9). These observations closely recapitulate our in vitro analyses of 253 
parasite clones and indicate that transient polysomies may contribute to parasite adaptation 254 
in vivo. 255 
256 
Long-term genetic implications on genetic diversity 257 
Maintaining diversity under strong selection poses a dilemma for all microbial pathogens, 258 
since it requires a mechanism that permits some compromise between immediate survival 259 
through selection and long-term adaptation through the maintenance of genetic diversity. We 260 
therefore searched for traces of increased genetic diversity associated with frequent 261 
aneuploidies and found a clear signal in the 204 field isolates (Fig. 6). Integrating genetic 262 
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variation across each individual isolate shows that polysomy-prone chromosomes exhibit a 263 
significantly higher level of heterozygous sites than their more stable counterparts. This 264 
trend is especially strong for chr 31, which has the most stable, frequent and highest order 265 
aneuploidy. This finding suggests that L. donovani might utilize aneuploidy to accumulate 266 
mutations and increase its diversity. Further, these results confirm that even though transient 267 
in vivo aneuploidies are difficult to detect and quantify, they are frequent enough to shape 268 
the parasite genome and its genetic diversity. 269 
 270 
Discussion 271 
Utilizing recently published genomes of 204 field isolates19 and conducting evolutionary 272 
experiments, we demonstrated that karyotypic variation modulates transcript abundance and 273 
thus likely generates considerable phenotypic variability with possible fitness gains 274 
associated with tissue-specific haplotype selection in situ. The genomic landscape defined 275 
by an exhaustive combination of all possible trisomies, disomies and monosomies along with 276 
their haplotype variations is substantial and at least one order of magnitude larger than a 277 
similar estimate recently made on the basis of aneuploidy variations23. Aneuploidy turnover 278 
therefore provides an efficient alternative to sex-based haplotype selection. This mechanism 279 
may be especially useful within the mammalian host, where the absence of sexual 280 
reproduction creates an even heavier selective pressure on the parasite’s survival prospects. 281 
Rapid aneuploidy turnover combined with haplotype selection permits fast adaptation 282 
but comes with a significant genetic cost. Since alleles with lowered frequencies are at a 283 
higher risk of disappearing from the genetic pool25, haplotype selection may induce loss of 284 
heterozygosity. The transient trisomy of chr 20 and its in vivo, tissue-specific haplotypic 285 
diversity illustrates the dilemma for the parasite between over-adaptation to any given 286 
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environment that may involve irreversible genetic tradeoffs and maintenance of sufficient 287 
genetic diversity for future adaptations. In this chromosome, the loss of heterozygosity could 288 
contribute to adaptation across conditions and tissues, however this same process may also 289 
yield an evolutionary dead end. The evolutionary success of Leishmania testifies of its ability 290 
to establish a delicate balance between these conflicting requirements for short- and long-291 
term adaptation. Long-term survival for the parasite involves two complementary 292 
mechanisms to generate and maintain genetic diversity. The first one relies on the mosaic 293 
origin of selected populations. We demonstrated that culture adapted isolates do not have a 294 
single founding parent but result from the simultaneous selection of several individuals. This 295 
process maintains a high level of karyotypic and haplotypic diversity allowing polysomies to 296 
occur frequently and independently in genetically distinct individuals. The second source of 297 
diversity is a direct consequence of the relaxed selection that occurs after gene or 298 
chromosome duplication26. Our findings agree with these models and further suggest that 299 
aneuploidy-prone chromosomes have significantly higher mutation rates than their more 300 
stable counterparts. Thus, aneuploidy represents an additional powerful mechanism to 301 
increase genetic diversity in L. donovani. 302 
Leishmania, like all known infectious agents, provides us with an excellent example 303 
of genetic selection driven by survival. But it does so in a very unusual way: while high 304 
mutation rates and genetic material exchange through sexual or analogous mechanisms 305 
mediate survival in most pathogens, Leishmania evolved an additional strategy based on 306 
genome instability to enhance parasite evolvability27–29. We show here that the parasite 307 
harnessed this process and efficiently combined it with haplotype selection for rapid and 308 
efficient genome adaptation under environmental pressure. This strategy has direct 309 
consequences for current protocols in Leishmania drug and biomarker discovery. First, 310 
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Leishmania genome instability limits all current and future drugs that directly target the 311 
parasite biology and select for resistance phenotypes30,15,14. New strategies for anti-312 
leishmanial drug discovery should avoid direct parasite selection and rather target the 313 
parasites’ dependence on host cell metabolism. Second, the massive genomic changes we 314 
observed during Leishmania culture adaptation challenges current protocols for biomarker 315 
discovery, which all rely on in vitro expansion of clinical isolates. In the light of our findings, 316 
we should modify these protocols to identify additional biomarkers hidden/diluted by culture-317 
based methods especially when polysomy itself is considered a biomarker. Alternatively, we 318 
could establish culture-independent approaches that propagate field isolates in experimental 319 
animal models or apply direct tissue sequencing. It is clear that genome instability needs to 320 
be considered when investigating medically relevant aspects of the parasite’s phenotype, 321 
such as tissue tropism, drug susceptibility and pathogenicity. Our findings establish a 322 
foundation for the future discovery of haplotypes with diagnostic and prognostic value.  323 
324 
325 
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15 
Material and Methods 328 
 329 
L. donovani strains, culture conditions and cell cloning. Culture-adapted L. donovani 330 
field isolates maintained for more than 20 in vitro passages from the Indian Sub-Continent 331 
were used in our analyses to track evolutionary diversity maintained across populations19. 332 
Isolates were not sub-cloned and populations were used for all studies. Infectious L. 333 
donovani strain 1S2D (MHOM/SD/62/1S-CL2D, referred to here as LD1S) was obtained 334 
from Henry Murray (Weill Cornell Medical College, New York, USA) and maintained in 335 
hamsters by serial passaging (see below). All LD1S studies were performed with populations 336 
except when specified otherwise. For promastigote differentiation and culture, 1 x 107 LD1S 337 
amastigotes purified from hamster spleens were cultured at 26 °C in M199 media 338 
supplemented with 10 % FCS, 25 mM HEPES pH 6.9, 4 mM NaHCO 3 1 mM glutamine, 1 x 339 
RPMI 1640 vitamin mix, 0.2 μM folic acid, 100 μM adenine, 7.6 mM hemin, 8 µM biopterin, 340 
50 U/ml of penicillin, and 50 μg/ml of streptomycin. Promastigotes were then maintained in 341 
culture by serial dilution in fresh medium once they reached stationary phase. At passages 342 
2, 10 and 20 corresponding to approximately 20, 60 and 190 generations respectively, 343 
parasites in exponential growth phase were collected and adjusted to 2 x 108 parasites per 344 
tube for DNA extraction (see below). After 20 in vitro passages, serial dilutions of 345 
promastigotes were plated on M199 Agar plates and 8 clones were selected and amplified in 346 
promastigote medium. 347 
 348 
Hamster infection and isolation of infectious amastigotes. We used female 349 
RjHan:AURA golden syrian hamsters between 4 to 6 weeks of age (Janvier Labs, France) 350 
and a weight between 60 to 90g. Housing of the animals and all experiments were 351 
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conducted in agreement with the project number 2013-0092 approved by the Institut Pasteur 352 
Ethics committee in accordance to the European legislation/guidelines EU 2010/63. We 353 
used a total of 13 hamsters for DNA-FISH analysis (1), DNA/RNA extraction from purified 354 
amastigotes (2), hamster infection (6), monitor tissue parasite burden (3), and comparative 355 
HTseq analysis of liver and spleen amastigotes (1). Given the nature of our animal 356 
experiments to compare infected versus non-infected animals and use infected animals as a 357 
source of biological material, our studies were not blinded or randomized. No animals were 358 
excluded from analysis. Anesthetized hamsters were inoculated by intra-cardiac injection 359 
with 5 x 107 amastigotes obtained from infected hamster spleens. Hamster weight was 360 
monitored and animals were euthanized with CO2 after four months of infection. Spleens and 361 
livers were collected, weighed, and homogenized in PBS as described31. For amastigote 362 
purification, tissues were homogenized in 25 ml PBS supplemented with 2.5 mg/ml saponine 363 
using the gentleMACS homogenizer and gentleMACS M tubes from Miltenyi. Homogenates 364 
were cleared by centrifugation at 130g for 5 min at 4°C, the supernatants were collected, 1 365 
ml of saponine (25 mg/ml) was added under gentle agitation, and parasites were harvested 366 
5 min later by centrifugation at 2000g for 10 min at 4°C. After two washing steps with PBS, 367 
remaining host cell contaminants were removed by Percoll centrifugation. Briefly, parasite 368 
were resuspended in 6 ml of 45 % Percoll, and 3 ml were layered on a cushions of 2 ml of 369 
90 % Percoll in 15 ml falcon tubes. After 35 min of centrifugation at 3500g, 15°C, 370 
amastigotes were recovered from the interface of the gradient and washed 3 times in PBS 371 
(centrifugation at 2000g, 10min, 4°C). Tissue-derived amastigotes were adjusted to 2 x 108 372 
parasites per tube for RNA or DNA extraction or inoculated in culture medium for 373 
differentiation into promastigotes and further culture. 374 
375 
17 
DNA FISH analysis. DNA probes for chromosomes 5, 17, 22, and 27 were prepared as 376 
described in18. Amastigotes were purified from infected hamster livers and spleens 377 
(previously inoculated with amastigotes obtained from infected hamster spleens) as 378 
described above, immobilized on glass slides, fixed in 4% paraformaldehyde and 4% acetic 379 
acid. Fluorescence in situ hybridization was performed according to Sterkers et al.18. 380 
Leishmania cells were viewed by phase contrast, and fluorescence was visualized using 381 
appropriate filters on a ZeissAxioplan 2 microscope with a 100 x objective. Digital images 382 
were captured using a Photometrics CoolSnap CDD camera (Roper Scientific) and 383 
processed with MetaView (Universal Imaging). Z-Stack image acquisitions (15 planes of 384 
0.25 mm) were systematically performed for each cell analyzed using a Piezo controller, 385 
allowing to view the nucleus in all planes and to count the total number of labeled 386 
chromosomes. The ploidy was estimated on 100 labeled cells. We carefully considered the 387 
cell cycle state and excluded cells that were replicating their DNA as judged by the presence 388 
of large or duplicated kinetoplasts, which corresponded to less than1% and thus a negligible 389 
fraction. This low replication rate was confirmed by our own infection data analysis that 390 
allowed us to calculate a generation time of amastigotes in vivo of 10.4 days.  391 
392 
  393 
Genomic sequencing. All sequencing analysis were performed using Illumina short-read 394 
technology. The sequences for BPK282/0 promastigotes and amastigotes shown in Figure 395 
2a were generated using the Nextera XT library preparation kit (Illumina), the KAPA Library 396 
Quantification Kits (KAPA Biosystems), and paired-end sequencing on a HTSeq 1500 397 
sequencer (Illumina). The sequences of LD1S liver and spleen amastigotes (Figure 5c, 398 
Supplementary Figure 8 and 9) were carried out as a service by the Centro Nacional de 399 
18 
Análisis Genómico (CNAG, Barcelona) using the following protocol: 0.3-0.6 micrograms of 400 
sheared genomic DNA (Covaris E201) was end-repaired, adenylated and ligated to Illumina 401 
specific indexed paired-end adapters (adapter:insert molar ratio 40:1). The DNA library was 402 
size selected with AMPure XP beads in order to reach an insert size of 220-550bp and to 403 
remove unligated adapters. The final libraries were quantified with the Library Quantification 404 
Kit (Kapa Biosystems). On the base of the qPCR quantification the molar concentration 405 
sufficient for sequencing run was estimated. Each library was sequenced using TruSeq SBS 406 
Kit v3-HS (Illumina Inc.), in paired end mode, 2x101bp, in a fraction of one sequencing lane 407 
of an HTSeq2000 flowcell v3 (Illumina Inc.) according to standard Illumina operation 408 
procedures with a yield between 3,593 - 6,326 Gb for each sample. The rest of the LD1S 409 
Leishmania sequences were generated at the Centre for Genomic Regulation (CRG, 410 
Barcelona) using the following protocol: DNA was isolated using DNeasy blood and tissue 411 
kits from Qiagen, nucleic acid concentration was measured with a NanoDrop® spectrometer, 412 
and between 2 to 5 µg were used for sequencing and quality control. DNA sequencing was 413 
performed using an Illumina HiSeq 2000 platform and TruSeq v3 kits. One µg of nucleic 414 
acids was used for DNAseq while the rest of the material was used for quality control. All 415 
libraries were sequenced in 125 bp reads. A summary of the read numbers and read-length 416 
associated with each genome is provided in Supplementary Table 2.  417 
 418 
Read depth Sequencing Analysis. All DNA sequences were mapped against L. donovani 419 
BPK282A1 from TriTrypDBv7. Mapping and post processing was carried out using a 420 
combination of BWA mem (v0.7.8)32 along with Samtools (v1.3)33 in order to refine read 421 
information and clean mapped sequences. Alignments were further refined using GATK 422 
(v2.8) IndelRealigner and MarkDuplicates34. Samtools depth command was used to estimate 423 
19 
read-depth for every base, so as to determine median read-depth for each chromosome. In 424 
order to estimate chromosome polysomy level in each sample, chromosome 34 - which 425 
showed a stable disomic level across samples - was used to normalize other chromosomes 426 
read depth. This measure was calibrated to determine polysomy levels, under the 427 
assumption that the most frequent polysomy levels correspond to disomy. Intermediate 428 
polysomy levels were classified as trisomic or tetrasomic events by using cutoffs on the 429 
normalized chromosome read depth values. Chromosomes with values ranging between 2.6 430 
and 3.4 were classified as trisomic, and values between 3.6 and 4.4 as tetrasomic. These 431 
calibrated values were used to select subsets of chromosomes having comparable 432 
aneuploidy levels. (Accession number: PRJEA61817) 433 
 434 
Aneuploidy co-occurrence. Aneuploidy co-occurrence analysis was carried out by 435 
measuring the Pearson correlations between pairs of chromosomes, with each chromosome 436 
being represented as vector of normalized depth values, each value being drawn from an 437 
isolate. P-Values were measured so as to identify pairs having the highest levels of co-438 
variation - as opposed to constant or unrelated polysomy levels.  439 
 440 
Variant calling and allele frequency analysis. Pileups were generated across the 441 
reference genome for all the samples. Samtools mpileup and its multiallelic caller were then 442 
used to detect variants separately in all samples. In order to filter out sites potentially 443 
affected by episomal amplifications, regions with a read-depth higher than 1.6 x the median 444 
depth of each chromosome were excluded from the analysis. The resulting sites were then 445 
used to draw allele frequency statistics, and produce allele frequency profiles. Variants were 446 
then filtered using a quality threshold of 15 using a Read Position Bias (RPB) filter of 0.1 and 447 
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alleles with frequencies comprised between 0.1 and 0.9 were retained. This approach, that 448 
was explicitly designed to prioritize sensitivity over specificity, yields about 10 times more 449 
sites than a more conservative approach (28071 vs 2418 sites 19,20). The expected rate of 450 
false positive associated with this procedure can be shown to be in the order of 3% (-451 
10*log10(1/31.6)). This amount of noise that would be incompatible with biomarker discovery 452 
does not compromise the current analysis focused on tracing homologue chromosome fate 453 
in aneuploidies.  454 
 455 
Merged allele frequency profiles. The allele frequencies associated with variants called as 456 
explained in the previous section were then used to build merged allele frequency 457 
distribution profiles for each chromosome across isolates. Profiles of homologue 458 
chromosomes classified with the same polysomy level - as explained in read depth analysis 459 
- were added up to yield a set of merged profiles (Supplementary Figure 1). The stacking of 460 
pre-computed profiles presents the advantage of maintaining the individual segregation 461 
profiles and can therefore be used to estimate profile homogeneity across samples as 462 
indicated by well-defined peaks that reflect conserved allelic frequencies across isolates. 463 
Most of these profiles exhibit the near canonical profiles expected for allele distribution in a 464 
diploid, triploid or tetraploid organism and therefore confirm the suitability of the noise to 465 
signal ratio of our site calling procedure.    466 
 467 
Segregation variations and Loss of Heterozygosity dispersion plots. Segregation 468 
variations (SV) between disomic and trisomic chromosomes were estimated by considering 469 
for each heterozygous site the log ratio between the frequency of the most major (major 470 
allele) allele in the considered isolate, and the average frequency of the same allele in the 471 
21 
disomic population. 472 
473 
With 474 
 - s heterozygote site in an isolate 475 
- t isolate trisomic for chromosome N 476 
 - T all the isolates trisomic for chromosome N 477 
 - d isolate disomic for chromosome N  478 
- D all the isolates disomic for chromosome N 479 
-MA(s,t) the Major Allele on site s in the isolate t trisomic for Chromosome N 480 
 -Frequency (MA(s,t),t) is the frequency of MA(s,t) in isolate t 481 
-AvgFrequency (MA(s,t),D) the average frequency of MA(s,t) across all isolates D 482 
disomic for Chromosome N 483 
484 
This procedure amounts to considering the disomic average as a null hypothesis with 485 
respect to the fate of the corresponding alleles in their trisomic states.  When doing so the 486 
nature of the allele is not considered and two isolates having different major alleles on the 487 
same site can nonetheless contribute the same value to the distribution of ratios, as plotted 488 
in Supplementary Figure S1b. These ratios were then averaged for each chromosome and 489 
used as a measure for Segregation variation. On Supplementary Fig S1, profiles are ordered 490 
according to this ratio that tends to reflect the disomic tendency in the trisomics. 491 
492 
Loss of heterozygosity (LOH) was estimated by considering for each trisomic 493 
heterozygous site the log odd ratio between the average frequency of the major allele across 494 
22 
trisomic isolates and the corresponding frequency across disomic isolates. These ratios 495 
were then averaged for each chromosome and used as a loss of heterozygosity measure 496 
using the following formula 497 
498 
With 499 
 - t isolate trisomic for chromosome N 500 
 - T all the isolates trisomic for chromosome N 501 
 - d isolate disomic for chromosome N  502 
- D all the isolates disomic for chromosome N 503 
-MA(s,T) the allele s that has the highest average frequency across all the T isolates 504 
trisomic for Chromosome N 505 
-AvgFrequency(MA(s,T),T) is the average frequency of MA(s,T) across all the T 506 
isolates trisomic for Chromosome N 507 
-AvgFrequency(MA(s,T),D) is the average frequency of MA(s,T) across all the D 508 
isolates disomic for Chromosome N 509 
510 
This measure reflects the tendency of a given allele to dominate in frequency the overall 511 
trisomic population. It makes it possible to discriminate between a scenario where the two 512 
original disomic alleles are equally likely to have increased frequencies in each isolate (i.e. 513 
random selection of the duplicated homologous chromosome), and situations where the 514 
same allele is consistently amplified across all isolates (i.e. clonal amplification of the same 515 
trisomy or consistent selection of the same homologous chromosome amplification). The 516 
comparison between SV and LOH across field isolates is shown in Fig1d, with a p-value 517 
23 
calculated as the t-test statistic based on Pearson's product moment correlation coefficient 518 
using cor.test() function in R. 519 
 520 
Haplotype phasing. Haplotype phasing was carried out by considering the effect of 521 
aneuploidy on the original frequencies following the protocol originally defined in 21. In this 522 
analysis, alleles undergoing similar shifts are considered as being part of the same 523 
haplotype block. While heterozygous SNPs are not dense enough in the 204 filed isolates for 524 
this approach to be validated, we took advantage of the LD1S hybrid origin to verify that 525 
SNPs occurring with the insert distances of the pair-ended sequencing had similar 526 
segregation shifts after duplication and could therefore considered to be genetically linked, 527 
thus ruling out recombination as a major confounding factor. This finding is in agreement 528 
with the original study of very low recombination rates in the 204 filed isolates. Our analysis 529 
indicates that 50% of the SNP pairs within insert distance of one another have allelic 530 
frequencies less that 10% point apart in the bimodal trisomics (Fig S11), as compared with 531 
23% when randomizing pair ends in order to test for pair connectivity and allele linkage. 532 
533 
Transcriptome sequencing. RNA was prepared using RNeasy mini plus blood and tissue 534 
kits from Qiagen according to manufacturer instructions. Nucleic acid concentrations were 535 
measured with a NanoDrop® spectrometer. RNA sequencing was performed using an 536 
Illumina Hiseq 2000 platform and TruSeq v3 kits. Four µg of nucleic acids were used for 537 
RNAseq and the rest of the material was used for the quality control. RNA libraries were 538 
sequenced on a single flow cell single stranded 51 bp read. Sequencing reads have been 539 
submitted to the European Nucleotide Archive (ENA) and are available under the submission 540 
number PRJEB15282. The amount and the length of reads obtained from each analysis are 541 
24 
summarized in the Supplementary Table 2. 542 
 543 
Relative expression estimation. Gene copy numbers and expression levels were 544 
estimated from DNA and RNA read counts respectively, mapping to annotated ORFs using 545 
reference gene annotation from TriTrypDBv7. The actual read-counts were measured with 546 
BedTools (v2.19)35 using the BAM files obtained after mapping. In order to normalize for 547 
gene length, read counts were estimated in Reads Per Kilobase Mapped (RPKM)36 across 548 
all genes and samples. These RPKM measurements were then used to compare expression 549 
levels across samples. 550 
 551 
Data availability. All Sequencing reads have been submitted to the European Nucleotide 552 
Archive (ENA) and are available under the Accession Number PRJEB15282. The amount 553 
and the length of reads obtained from each analysis are summarized in the Supplementary 554 
Table 2. 555 
 556 
Code availability 557 
Custom scripts and code necessary to generate figures and files can be found in the 558 
following repository: https://github.com/pprieto/genomevoleish 559 
 560 
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Figures 672 
Figure 1: Genome instability, aneuploidy co-occurrence and haplotype selection in 204 L. 673 
donovani field isolates. Polysomy analysis based on read-depth comparison and derived 674 
allele frequency analysis on specific aneuploidies is shown. (a) Polysomy analysis. 675 
Polysomy level was estimated for each chromosome and sample by read-depth analysis. 676 
The distribution of chromosome copy number is shown across all field isolates. (b) Co-677 
occurrence analysis. Pearson correlation measured for each pair of chromosomes was 678 
plotted while considering the median read depth measured in every field isolate. Empty 679 
positions correspond to either uncorrelated pairs or insignificant correlations (significance 680 
level of 0.05). One main cluster appears containing typically trisomic chromosomes. (c) 681 
Allele frequency profiles. Merged allele frequency distributions are shown for chromosomes 682 
1 and 5 for both disomic (right) and trisomic (left) states. (d) Segregation variation vs allele 683 
diversity analysis. This panel summarizes the relationship between segregation variations 684 
(SV, reflecting bi-modality of the merged frequency profiles) and loss of heterozygosity 685 
(LOH, reflecting allelic diversity) when comparing trisomic and disomic isolates across 204 686 
field isolates and the 36 chromosomes of the genome. For most chromosomes, both 687 
quantities are highly correlated as indicated by the blue regression line. 688 
 689 
Figure 2: In vivo aneuploidy dynamics. The three panels document the dynamic nature and 690 
the mosaicism of L. donovani aneuploidy in situ during hamster infection. (a) Aneuploidy 691 
pattern of L. donovani field isolate BPK282/0 after over 20 passages in culture (in vitro, iv) 692 
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and following three consecutive passages of these p>20 parasites in the hamster (H3). Heat 693 
maps show median normalized read depths of the 36 chromosomes in both samples and an 694 
estimation of the polysomy level of each chromosome: blue, two copies; green, three copies; 695 
yellow four copies. (b) DNA-FISH analysis.  L. donovani strain LD1S amastigotes purified 696 
from infected hamster liver (L) and spleen (S) were analyzed with fluorescent labeled probes 697 
specific for chromosomes (chr) 5, 17, 22, and 27 and signals were analyzed by microscopy. 698 
The signal for chr 5 in spleen-derived amastigotes is shown as an example (phase, phase 699 
contrast; FISH, fluorescent signal from DNA-FISH analysis; overlay, merged image of DNA-700 
FISH and nuclear signal obtained with DAPI stain). The bar corresponds to 2 μm. The % 701 
chromosome number was calculated counting 100 individual cells per condition (lower 702 
panel). The polysomy level is indicated by the bar filling, with white for monosomy, gray for 703 
disomy and black for trisomy. 704 
 705 
Figure 3. In vitro aneuploidy dynamics. This figure shows read-depth variations in L. 706 
donovani LD1S genes (8760 genes) across chromosomes at different passages during 707 
culture adaptation (4 samples) and in the 8 sub-clones derived from the parasite population 708 
at passage 20. Chromosome gene read-depth distributions are shown in boxplots depicting 709 
upper and lower quartiles and the median. (a) Read depth variation during culture 710 
adaptation. Variations in read-depth for L. donovani LD1S amastigotes isolated from infected 711 
hamster spleen (sp-ama) and derived promastigotes at passage 2, 10, and 20 (p2, p10, 712 
p20). Only aneuploid chromosomes are shown (see full panel in Supplementary Fig. 3a). 713 
Normalized read depth for every gene within each chromosome is displayed using a 714 
standard box-plot representation with the central line representing the median of the 715 
distribution. (b) Read depth variation on individual sub-clones. Variations on these same 716 
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chromosomes as shown in panel A are shown for 8 individual parasite cultures subcloned 717 
from p20 parasites (sub-clones are indicated by CL, for full panel see Supplementary Fig. 718 
3b). 719 
 720 
Figure 4: Fluctuations of allele frequency during culture adaptation. These panels document 721 
haplotype selection by following the allele frequency distribution in 8 sub-clones and the 722 
original p20 parasite population (n=9 samples in total) across . (a) Haplotype selection in 723 
clones. Variable sites in chromosomes undergoing amplification were either colored 724 
according to the major alleles (i.e. highest frequency) or left in gray for balanced 725 
heterozygote sites. Each painted pattern represents a chromosome, either from the original 726 
p20 population (first line) or one of the 8 derived sub-clones. Allele frequency distributions 727 
for each sample are shown on the left of each panel. The color code of the distributions 728 
corresponds to the read depth, with disomic-to-trisomic-to-tetrasomic transitions indicated by 729 
a continuum colored from red to green. The number of heterozygous sites for each 730 
chromosome and sample are shown by the histograms (right side of each panel). Samples 731 
with low counts as observed for chromosomes 15 and 20 represent loss of heterozygosity 732 
occurring during culture adaptation. (b) Haplotype selection during culture adaptation. Allele 733 
frequency distributions corresponding to hamster-derived splenic amastigotes (sp-ama) and 734 
derived promastigotes during culture adaptation at passage p2, p10 and p20 are shown for 735 
selected chromosomes. All chromosomes undergoing polysomy variations are displayed in 736 
Supplementary Fig. 3. 737 
 738 
Figure 5: Aneuploidies and haplotype selection correlate with phenotype and fitness. This 739 
figure shows the relationship between aneuploidy and haplotype selection with 740 
33 
transcriptomic output, in vitro and in vivo growth, and tissue-specific parasite adaptation. (a) 741 
Correlation of aneuploidy and transcript output. Each dot corresponds to a chromosome with 742 
the X-axis reflecting the transcriptome median read-depth and the Y-axis the corresponding 743 
genomic median read-depth, as estimated for the eight subclones. A subset of 744 
chromosomes was colored as indicated by the legend. (b) Parasite growth phenotype in vitro 745 
and in vivo. LD1S promastigotes during culture adaptation at passages p2, p10, and p20 746 
were assessed for in vitro growth to determine the generation time (left panel). Three 747 
independent triplicate experiments were performed and results of one representative 748 
experiment with standard deviation represented by the error bars is shown. In vivo parasite 749 
growth was assessed in infected hamster spleens and livers by limiting dilution assay 750 
(middle panel). The plot represents the mean parasite burden +/- SD of three infected 751 
hamsters. Pathogenicity was monitored following hamster weight as a function of time (right 752 
panel) for three non-infected and three infected hamsters. (c) Tissue-specific haplotype 753 
selection. Amastigotes were isolated from liver and spleen of one infected hamster, purified 754 
genomic DNA was subjected to HTseq analysis, and allele profiles were established by 755 
plotting allele density versus frequency. 756 
757 
 758 
Figure 6: Aneuploidy influence on heterozygosity. Each chromosome is represented by its 759 
number on the graph and colored according to aneuploidy frequency after culture 760 
adaptation, as measured in the 204 L. donovani field isolates. The two lines (blue and green) 761 
show apparent regimens of mutation rates. The green line fits a linear model for 762 
chromosomes with an aneuploidy frequency higher than 25%, while the blue line indicates 763 
chromosomes that are lower in frequency. Chromosome 31 is excluded from the fitted 764 
34 
models as it stands out as the only chromosome with aneuploidy in all samples. 765 
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